Development of anti-major histocompatibility complex class I or II antibodies following left ventricular assist device implantation: effects on subsequent allograft rejection and survival.

Source:http://linkedlifedata.com/resource/pubmed/id/11404170

Download in:

View as

General Info

PMID
11404170